ArticleCellular and molecular gastroenterology and hepatology2022
Cannabinoid Receptor 1 Antagonism Demonstrates High Therapeutic Potential for the Treatment of Primary Sclerosing Cholangitis.
Lindsey Kennedy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.